高富集團(00263.HK)一名獨立非執董被證監會列為應訴人
高富集團(00263.HK)公布,接獲一位獨立非執行董事黃潤權告知,證監會就奇峰國際(已於2020年6月除牌)向香港高等法院原訟法庭提交日期為2020年12月18日之呈請中,彼被列為應訴人之一。
證監會於呈請中指稱,該除牌公司的董事(包括黃博士,彼從2007年4月至2010年6月作為獨立非執行董事)沒有以應盡及合理的謹慎、技能和努力履行彼等作為該除牌公司管理層之職責。
董事會已獲黃告知彼不同意證監會在呈請中所作的指稱,並將對呈請竭力抗辯。
鑒於該呈請不涉及公司或其任何附屬公司及黃亦無參與集團的日常運作,董事會認為該呈請將不會為集團之業務營運或財務狀況帶來任何重大的不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.